clinical trial · NCT05817643
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
Alzheimer DiseaseDementiaBMS-984923
brief summary
This project is developing a novel disease-modifying compound for Alzheimer's disease (AD).
started
Jan 10, 2023
primary completion
Feb 27, 2023
completion
Nov 15, 2024
last updated
Jul 30, 2024
detailed description
The primary objective of this study is to evaluate for an effect of food consumption on the pharmacokinetics profile of BMS984923. Safety and tolerability is also assessed.
official title
A Randomized, Open-label, 2-period, Crossover, Pilot Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol